Neuland Laboratories Opens QbD-centered Process Engineering Lab

News
Article

Featuring software, parallel automated reactors, and other tools designed to facilitate design of experiments, development of the design space, and better process understanding and control, the Hyderabad facility came online on July 20

Neuland Laboratories Ltd, a contract development and manufacturing organization specializing in APIs, custom intermediates, and custom manufacturing solutions has started up a new process engineering lab at its R&D center in Hyderabad. The goal of the new facility is to support the pharmaceutical quality by design (QbD) approach to drug development, by featuring instrumentation, software, and systems designed to facilitate the use of QbD for drug substances and intermediates development.

"Our new process engineering lab integrates the key attributes of QbD: Process understanding, process control, and continuous improvement with advanced equipment, Design of Experiments Software, and Design Space methodology, to optimize process design, operations, and productivity," says Saharsh Davuluri, Joint Managing Director at Neuland.

The new facility features the following:

·      A stirred, controlled reaction calorimeter from the HEL Group that measures the rate of heat release during reactions

·      Automated parallel HEL reactors that enable a chemist to perform multiple experiments at temperatures ranging from -60 oC to 225 oC

·      A thermal screening unit (TSU), which indicates the thermal stability of chemicals and safe processing temperatures. Ideal for risk analysis, the TSU uses only 0.5-5 g of sample.

"This important addition to our capabilities will better enable Neuland to develop cost-effective procedures and quality products, meet regulatory requirements, improve scale-up efficiency, and accelerate time to market," says Dr. Ravi Ponnaiah, President, Science and Technology.

As he explains, a QbD approach includes three fundamental elements:

1) a clear understanding of the target product profile;

2) determination of critical quality attributes (CQAs) and

3) ensuring that processes and products remain within defined range limits.

Continual risk assessment of all aspects of a process, from the quality of the raw materials to the process parameters and their potential effects on CQAs enables continuous improvement of processes and products.

A QbD program relies on applying this information to develop a design space and a process control strategy, continually monitoring the process to assess its capabilities, introducing changes to improve product quality, cost, and process efficiency.

Source: Company press release 

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content